Literature DB >> 2523995

In vitro photosensitization I. Cellular uptake and subcellular localization of mono-L-aspartyl chlorin e6, chloro-aluminum sulfonated phthalocyanine, and photofrin II.

W G Roberts1, M W Berns.   

Abstract

The mechanisms of cellular uptake, subcellular localization, and cellular retention kinetics of the photosensitizers photofrin II (PfII), mono-L-aspartyl chlorin e6 (MACE), and chloro-aluminum sulfonated phthalocyanine (CASPc) are reported in this paper. Each photosensitizer's cellular uptake mechanism was determined by preferentially inhibiting endocytosis by chilling cells to 2 degrees C, while allowing diffusion across the membrane. Subcellular localization was studied by computer-enhanced low-light level video fluorescence microscopy, while flow cytometry was used to determine uptake and retention kinetics. The results indicate that PfII enters the cell primarily by diffusion across the membrane, whereas MACE and CASPc enter the cell through endocytosis.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2523995     DOI: 10.1002/lsm.1900090203

Source DB:  PubMed          Journal:  Lasers Surg Med        ISSN: 0196-8092            Impact factor:   4.025


  15 in total

1.  In vitro behavior of Porfimer sodium and Talaporfin sodium with high intensity pulsed irradiation.

Authors:  Sayaka Ohmori; Tsunenori Arai
Journal:  Lasers Med Sci       Date:  2006-09-22       Impact factor: 3.161

Review 2.  Photodynamic therapy for pancreatic and biliary tract carcinoma.

Authors:  Lakshmana Ayaru; Stephen G Bown; Stephen P Pereira
Journal:  Int J Gastrointest Cancer       Date:  2005

3.  Killing tumor cells: the effect of photodynamic therapy using mono-L-aspartyl chlorine and NS-398.

Authors:  Elizabeth H Harvey; John Webber; David Kessel; David Fromm
Journal:  Am J Surg       Date:  2005-03       Impact factor: 2.565

Review 4.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

5.  Photodynamic tumor therapy: mitochondrial benzodiazepine receptors as a therapeutic target.

Authors:  A Verma; S L Facchina; D J Hirsch; S Y Song; L F Dillahey; J R Williams; S H Snyder
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

6.  Tetrakis(p-carboranylthio-tetrafluorophenyl)chlorin (TPFC): application for photodynamic therapy and boron neutron capture therapy.

Authors:  Ryo Hiramatsu; Shinji Kawabata; Hiroki Tanaka; Yoshinori Sakurai; Minoru Suzuki; Koji Ono; Shin-ichi Miyatake; Toshihiko Kuroiwa; Erhong Hao; M Graça H Vicente
Journal:  J Pharm Sci       Date:  2014-12-26       Impact factor: 3.534

7.  Low-level light therapy potentiates NPe6-mediated photodynamic therapy in a human osteosarcoma cell line via increased ATP.

Authors:  Shang-Ru Tsai; Rui Yin; Ying-Ying Huang; Bor-Ching Sheu; Si-Chen Lee; Michael R Hamblin
Journal:  Photodiagnosis Photodyn Ther       Date:  2014-11-13       Impact factor: 3.631

8.  Photodynamic therapy using talaporfin sodium for synovial membrane from rheumatoid arthritis patients and collagen-induced arthritis rats.

Authors:  Eiji Torikai; Yasunori Kageyama; Eiji Kohno; Toru Hirano; Yukio Koide; Susumu Terakawa; Akira Nagano
Journal:  Clin Rheumatol       Date:  2007-12-08       Impact factor: 2.980

9.  Synthesis and characterization of mono-, di-, and tri-poly(ethylene glycol) chlorin e6 conjugates for the photokilling of human ovarian cancer cells.

Authors:  Stanley Kimani; Goutam Ghosh; Ashwini Ghogare; Benjamin Rudshteyn; Dorota Bartusik; Tayyaba Hasan; Alexander Greer
Journal:  J Org Chem       Date:  2012-11-14       Impact factor: 4.354

10.  Uptake and retention of the photosensitizer mono-L-asparthyl chlorine e6 in experimental malignant glioma.

Authors:  Hiroyuki Matsumura; Jiro Akimoto; Jo Haraoka; Katsuo Aizawa
Journal:  Lasers Med Sci       Date:  2007-08-17       Impact factor: 3.161

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.